E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedReviewed
Standard · 3 min
Plasma cytokine expression in adolescent chronic fatigue syndrome.
Wyller, Vegard Bruun, Sørensen, Øystein, Sulheim, Dag et al. · Brain, behavior, and immunity · 2015 · DOI
Quick Summary
This study measured inflammation markers called cytokines in the blood of 120 adolescents with ME/CFS and compared them to 68 healthy young people. Despite CFS patients reporting significantly more fatigue and symptoms suggesting inflammation, the researchers found no differences in cytokine levels or inflammation patterns between the two groups. This suggests that the fatigue and symptoms in adolescent ME/CFS may not be caused by the type of low-grade inflammation in the blood that researchers had previously suspected.
Why It Matters
This study challenges a widely held hypothesis that low-grade systemic inflammation drives ME/CFS symptoms in adolescents, potentially redirecting research toward other mechanisms (neurological, metabolic, immunological pathways beyond circulating cytokines). Understanding why symptoms feel inflammatory when biomarkers don't reflect this is crucial for developing targeted treatments for young patients.
Observed Findings
CFS patients had significantly higher fatigue scores and self-reported inflammatory symptoms compared to controls (p<0.001)
No statistically significant differences in any of the 27 individual plasma cytokines measured between CFS patients and healthy controls
Cytokine network parameters derived from ARACNE analysis were similar between groups
No correlations found between cytokine levels or network measures and symptom severity scores within the CFS group
Findings remained unchanged when analysis was restricted to patients meeting strict Fukuda diagnostic criteria
Inferred Conclusions
Low-grade systemic inflammation measured via plasma cytokines does not appear to be a central pathophysiologic mechanism in adolescent ME/CFS
The disconnect between reported inflammatory symptoms and absence of elevated blood cytokines suggests other biological mechanisms may underlie disease pathophysiology
Circulating cytokine measurement alone may be insufficient to characterize immune abnormalities in adolescent ME/CFS
Remaining Questions
Why do CFS patients report inflammatory symptoms when circulating cytokine levels are normal—could local tissue inflammation, cellular immune dysfunction, or other immune alterations be present?
What This Study Does Not Prove
This study does not prove inflammation plays no role in ME/CFS—it only shows that standard circulating cytokine measurements are not elevated in adolescent patients at the time of testing. Local tissue inflammation, other immune markers (antibodies, cellular immunity), or cytokine abnormalities at other timepoints are not ruled out. The negative findings also do not explain what actually causes the symptoms patients experience.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.